Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 2/10

vs
industry
vs
history
Cash-to-Debt 0.37
TNDM's Cash-to-Debt is ranked lower than
70% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 2.54 vs. TNDM: 0.37 )
Ranked among companies with meaningful Cash-to-Debt only.
TNDM' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.37  Med: 2.29 Max: 4.41
Current: 0.37
0.37
4.41
Equity-to-Asset -0.19
TNDM's Equity-to-Asset is ranked lower than
93% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. TNDM: -0.19 )
Ranked among companies with meaningful Equity-to-Asset only.
TNDM' s Equity-to-Asset Range Over the Past 10 Years
Min: -2.66  Med: 0.45 Max: 0.71
Current: -0.19
-2.66
0.71
Debt-to-Equity -4.09
TNDM's Debt-to-Equity is ranked lower than
99.99% of the 204 Companies
in the Global Medical Devices industry.

( Industry Median: 0.29 vs. TNDM: -4.09 )
Ranked among companies with meaningful Debt-to-Equity only.
TNDM' s Debt-to-Equity Range Over the Past 10 Years
Min: -39.49  Med: 0.34 Max: 11.4
Current: -4.09
-39.49
11.4
Piotroski F-Score: 2
Altman Z-Score: -7.74
Beneish M-Score: -1.49
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating Margin % -100.55
TNDM's Operating Margin % is ranked lower than
78% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 3.45 vs. TNDM: -100.55 )
Ranked among companies with meaningful Operating Margin % only.
TNDM' s Operating Margin % Range Over the Past 10 Years
Min: -1335.27  Med: -152.17 Max: -92.64
Current: -100.55
-1335.27
-92.64
Net Margin % -110.70
TNDM's Net Margin % is ranked lower than
77% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 1.77 vs. TNDM: -110.70 )
Ranked among companies with meaningful Net Margin % only.
TNDM' s Net Margin % Range Over the Past 10 Years
Min: -1333.94  Med: -159.94 Max: -99.05
Current: -110.7
-1333.94
-99.05
ROE % -4029.52
TNDM's ROE % is ranked lower than
99% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 2.13 vs. TNDM: -4029.52 )
Ranked among companies with meaningful ROE % only.
TNDM' s ROE % Range Over the Past 10 Years
Min: -4029.52  Med: -206.37 Max: -93.5
Current: -4029.52
-4029.52
-93.5
ROA % -86.23
TNDM's ROA % is ranked lower than
86% of the 324 Companies
in the Global Medical Devices industry.

( Industry Median: 0.49 vs. TNDM: -86.23 )
Ranked among companies with meaningful ROA % only.
TNDM' s ROA % Range Over the Past 10 Years
Min: -182.5  Med: -66.52 Max: -59.2
Current: -86.23
-182.5
-59.2
ROC (Joel Greenblatt) % -323.21
TNDM's ROC (Joel Greenblatt) % is ranked lower than
76% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 6.15 vs. TNDM: -323.21 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
TNDM' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -598.61  Med: -462.37 Max: -308.73
Current: -323.21
-598.61
-308.73
3-Year Revenue Growth Rate -34.60
TNDM's 3-Year Revenue Growth Rate is ranked lower than
91% of the 239 Companies
in the Global Medical Devices industry.

( Industry Median: 5.30 vs. TNDM: -34.60 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
TNDM' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: -42.4 Max: -34.6
Current: -34.6
3-Year EBITDA Growth Rate -49.90
TNDM's 3-Year EBITDA Growth Rate is ranked lower than
95% of the 210 Companies
in the Global Medical Devices industry.

( Industry Median: 6.30 vs. TNDM: -49.90 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
TNDM' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -75.6  Med: -72 Max: -49.9
Current: -49.9
-75.6
-49.9
3-Year EPS without NRI Growth Rate -49.70
TNDM's 3-Year EPS without NRI Growth Rate is ranked lower than
93% of the 206 Companies
in the Global Medical Devices industry.

( Industry Median: 2.90 vs. TNDM: -49.70 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
TNDM' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -75.8  Med: -71.6 Max: -49.7
Current: -49.7
-75.8
-49.7
GuruFocus has detected 3 Warning Signs with Tandem Diabetes Care Inc $TNDM.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» TNDM's 30-Y Financials

Financials (Next Earnings Date: 2017-11-01 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2016

TNDM Guru Trades in Q3 2016

Jim Simons 356,400 sh (+21.10%)
Steven Cohen 983,514 sh (+15.71%)
» More
Q4 2016

TNDM Guru Trades in Q4 2016

Steven Cohen Sold Out
Jim Simons 304,400 sh (-14.59%)
» More
Q1 2017

TNDM Guru Trades in Q1 2017

John Paulson 500,000 sh (New)
Jim Simons 166,400 sh (-45.34%)
» More
Q2 2017

TNDM Guru Trades in Q2 2017

Jim Simons 177,800 sh (+6.85%)
John Paulson 500,000 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with TNDM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
John Paulson 2017-03-31 New Buy0.01%$1.1 - $2.75 $ 0.59-73%500,000
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339112    SIC: 3841
Compare:OTCPK:MRIC, NAS:MDVX, OTCPK:LCTC, OTCPK:BSGM, OTCPK:SMLR, ASX:GID, NAS:KOOL, NAS:MGCD, NAS:ETRM, OTCPK:IVOB, AMEX:MYO, OTCBB:NAOV, OTCPK:SNWV, OTCPK:BTCY, AMEX:XTNT, OTCPK:NIMU, OTCPK:VASO, NAS:AMDA, OTCPK:ABMT, NAS:DYNT » details
Traded in other countries:TD5.Germany,
Headquarter Location:USA
Tandem Diabetes Care, Inc. is a provider of medical care devices in the United States. Its products aid in the delivery of insulin and getting accurate readings through its software application.

Tandem Diabetes Care, Inc. is active in the United States healthcare sector. Its business is to address the diabetes disease by providing three insulin pump products such as t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System. It also offers software, which includes a touch screen and a micro- universal serial bus (USB) connection that uploads data from the pump and supported blood glucose meters to its products. The company's revenue is generated from the sales of insulin pumps, disposable cartridges and infusion sets to its customers in the United States.

Ratios

vs
industry
vs
history
PS Ratio 0.25
TNDM's PS Ratio is ranked higher than
96% of the 290 Companies
in the Global Medical Devices industry.

( Industry Median: 3.32 vs. TNDM: 0.25 )
Ranked among companies with meaningful PS Ratio only.
TNDM' s PS Ratio Range Over the Past 10 Years
Min: 0.19  Med: 2.54 Max: 8.83
Current: 0.25
0.19
8.83
EV-to-EBIT -0.93
TNDM's EV-to-EBIT is ranked lower than
99.99% of the 177 Companies
in the Global Medical Devices industry.

( Industry Median: 24.67 vs. TNDM: -0.93 )
Ranked among companies with meaningful EV-to-EBIT only.
TNDM' s EV-to-EBIT Range Over the Past 10 Years
Min: -10.1  Med: -3.4 Max: -0.7
Current: -0.93
-10.1
-0.7
EV-to-EBITDA -1.00
TNDM's EV-to-EBITDA is ranked lower than
99.99% of the 183 Companies
in the Global Medical Devices industry.

( Industry Median: 17.99 vs. TNDM: -1.00 )
Ranked among companies with meaningful EV-to-EBITDA only.
TNDM' s EV-to-EBITDA Range Over the Past 10 Years
Min: -10.6  Med: -3.6 Max: -0.8
Current: -1
-10.6
-0.8
EV-to-Revenue 0.94
TNDM's EV-to-Revenue is ranked higher than
89% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 3.70 vs. TNDM: 0.94 )
Ranked among companies with meaningful EV-to-Revenue only.
TNDM' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.7  Med: 4.1 Max: 20.2
Current: 0.94
0.7
20.2
Current Ratio 2.11
TNDM's Current Ratio is ranked higher than
52% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 2.64 vs. TNDM: 2.11 )
Ranked among companies with meaningful Current Ratio only.
TNDM' s Current Ratio Range Over the Past 10 Years
Min: 0.59  Med: 4.03 Max: 10.21
Current: 2.11
0.59
10.21
Quick Ratio 1.27
TNDM's Quick Ratio is ranked higher than
50% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 1.92 vs. TNDM: 1.27 )
Ranked among companies with meaningful Quick Ratio only.
TNDM' s Quick Ratio Range Over the Past 10 Years
Min: 0.59  Med: 3.32 Max: 9.5
Current: 1.27
0.59
9.5
Days Inventory 144.52
TNDM's Days Inventory is ranked lower than
51% of the 285 Companies
in the Global Medical Devices industry.

( Industry Median: 128.08 vs. TNDM: 144.52 )
Ranked among companies with meaningful Days Inventory only.
TNDM' s Days Inventory Range Over the Past 10 Years
Min: 116.18  Med: 117.75 Max: 298.88
Current: 144.52
116.18
298.88
Days Sales Outstanding 40.43
TNDM's Days Sales Outstanding is ranked higher than
90% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 68.17 vs. TNDM: 40.43 )
Ranked among companies with meaningful Days Sales Outstanding only.
TNDM' s Days Sales Outstanding Range Over the Past 10 Years
Min: 40.43  Med: 66.68 Max: 355.71
Current: 40.43
40.43
355.71
Days Payable 41.50
TNDM's Days Payable is ranked lower than
78% of the 258 Companies
in the Global Medical Devices industry.

( Industry Median: 54.45 vs. TNDM: 41.50 )
Ranked among companies with meaningful Days Payable only.
TNDM' s Days Payable Range Over the Past 10 Years
Min: 20.64  Med: 41.29 Max: 161.64
Current: 41.5
20.64
161.64

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -10.70
TNDM's 3-Year Average Share Buyback Ratio is ranked lower than
69% of the 226 Companies
in the Global Medical Devices industry.

( Industry Median: -4.10 vs. TNDM: -10.70 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
TNDM' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -444  Med: -418.2 Max: -10.7
Current: -10.7
-444
-10.7

Valuation & Return

vs
industry
vs
history
Price-to-Median-PS-Value 0.10
TNDM's Price-to-Median-PS-Value is ranked higher than
97% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 1.01 vs. TNDM: 0.10 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
TNDM' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.09  Med: 1.08 Max: 2.89
Current: 0.1
0.09
2.89
Earnings Yield (Greenblatt) % -107.28
TNDM's Earnings Yield (Greenblatt) % is ranked lower than
95% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 1.25 vs. TNDM: -107.28 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
TNDM' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -141.1  Med: -29.8 Max: -9.9
Current: -107.28
-141.1
-9.9

More Statistics

Revenue (TTM) (Mil) $81.51
EPS (TTM) $ -2.64
Short Percentage of Float6.15%
52-Week Range $0.39 - 8.81
Shares Outstanding (Mil)50.23

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 102 143 199
EPS ($) -1.94 -1.46 -0.34
EPS without NRI ($) -1.94 -1.46 -0.34
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for TNDM

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
No related articles found.

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}